Increased alpha 7 nicotinic acetylcholine receptor protein levels in Alzheimer's disease patients

被引:31
作者
Chu, LW
Ma, ESK
Lam, KKY
Chan, MF
Lee, DHS
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Geriatr, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Queen Mary Hosp, Div Haematol, Hong Kong, Hong Kong, Peoples R China
[3] Palomar Res Inc, Encinitas, CA USA
[4] Biogen Inc, Cambridge, MA 02142 USA
关键词
alpha 7 nicotinic acetylcholine receptor; blood leukocytes; Alzheimer's disease;
D O I
10.1159/000082661
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
We compared the intact alpha7 nicotinic acetylcholine receptor (alpha7nAChR) protein levels in the peripheral blood leukocytes in 15 Alzheimer's disease ( AD) patients and 13 normal elderly control subjects. Demographic data and Mini-Mental State Examination (MMSE) scores were obtained. Western blot analysis for alpha7nAChR protein levels in peripheral blood leukocytes was performed. There were no significant differences in sex and age between the AD and control groups. The mean MMSE score of the AD subjects was significantly lower than that of the normal control subjects (15.4 +/- 5.5 vs. 28.5 +/- 1.9 respectively; p < 0.001). The median value of normalized alpha 7nAChR protein levels ( optical density, arbitrary unit) of the AD group was significantly higher than that of the normal control group (0.6923 vs. 0.4803 respectively; p = 0.045, Mann-Whitney U test). The normalized alpha 7nAChR protein levels showed a significant inverse correlation with the MMSE scores ( Spearman rho = - 0.45; p = 0.016; n = 28). Receiver Operating Characteristic curve analyses showed that the area under curve was 0.72 ( 95% CI 0.52 - 0.87). If the cut-off of the alpha 7nAChR protein level was >0.312, the sensitivity, specificity, positive predictive value and negative predictive value would be 80, 39, 60 and 63%, respectively. These findings showed that the alpha7nAChR protein levels would be a potentially useful diagnostic marker for AD. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:106 / 112
页数:7
相关论文
共 36 条
[11]   Nicotinic receptor abnormalities in Alzheimer's disease [J].
Court, J ;
Martin-Ruiz, C ;
Piggott, M ;
Spurden, D ;
Griffiths, M ;
Perry, E .
BIOLOGICAL PSYCHIATRY, 2001, 49 (03) :175-184
[12]   Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies [J].
Etminan, M ;
Gill, S ;
Samii, A .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7407) :128-+
[13]   Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease [J].
Gasparini, L ;
Racchi, M ;
Binetti, G ;
Trabucchi, M ;
Solerte, SB ;
Alkon, D ;
Etcheberrigaray, R ;
Gibson, G ;
Blass, J ;
Paoletti, R ;
Govoni, S .
FASEB JOURNAL, 1998, 12 (01) :17-34
[14]   Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease [J].
Guan, ZZ ;
Zhang, X ;
Ravid, R ;
Nordberg, A .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (01) :237-243
[15]   Regional distribution of nicotinic receptor subunit mRNAs in human brain:: comparison between Alzheimer and normal brain [J].
Hellström-Lindahl, E ;
Mousavi, M ;
Zhang, X ;
Ravid, R ;
Nordberg, A .
MOLECULAR BRAIN RESEARCH, 1999, 66 (1-2) :94-103
[16]  
HELLSTROMLINDAH.E, 1997, ALZHEIMERS RES, V3, P29
[17]   A NEW CLINICAL-SCALE FOR THE STAGING OF DEMENTIA [J].
HUGHES, CP ;
BERG, L ;
DANZIGER, WL ;
COBEN, LA ;
MARTIN, RL .
BRITISH JOURNAL OF PSYCHIATRY, 1982, 140 (JUN) :566-572
[18]  
Lee DHS, 2000, ALZHEIMERS REP, V3, P217
[19]  
Leonard S, 2001, Nicotine Tob Res, V3, P203
[20]   Nicotinic receptor subtypes and cognitive function [J].
Levin, ED .
JOURNAL OF NEUROBIOLOGY, 2002, 53 (04) :633-640